Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jan 29, 2009


New England Peptide last week announced the appointment of Ved Srivastava to the newly created position of president for research production.

Srivastava will oversee NEP’s entire production pipeline.

Prior to joining NEP, he was associate director of discovery research at Amylin Pharmaceuticals, where he led the peptide chemistry team, discovery, synthesizing, and developing peptide hormones for diabetes, obesity, and neuropsychiatric therapies. He also directed the research chemistry team at Psylin Neurosciences, a joint venture between Amylin and PsychoGenics.

Srivastava had already been on NEP’s scientific advisory prior to his new appointment.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.